ID
16283
Description
Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00093002
Link
https://clinicaltrials.gov/show/NCT00093002
Keywords
Versions (1)
- 7/9/16 7/9/16 -
Uploaded on
July 9, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00093002
Eligibility Breast Cancer NCT00093002
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
previous treatment
Data type
boolean
Alias
- UMLS CUI [1]
- C1511300
Description
ID.7
Data type
boolean
Description
Comorbidities
Data type
boolean
Alias
- UMLS CUI [1]
- C0009488
Description
Number of primary tumors
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0449788
- UMLS CUI [1,2]
- C0677930
Description
hypersensitivity to castor oil
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0007343
Description
bleeding disorders
Data type
boolean
Alias
- UMLS CUI [1]
- C0005779
Similar models
Eligibility Breast Cancer NCT00093002
- StudyEvent: Eligibility
C0853879 (UMLS CUI [1,2])
C0405352 (UMLS CUI [1,2])
C0677930 (UMLS CUI [1,2])
C0007343 (UMLS CUI [1,2])